CHI3L1 and breast carcinoma: In conclusion, the present meta-analysis suggests that elevated YKL-40 expression is markedly associated with worse survival outcome in breast cancer patients, implying that YKL-40 may be a promising predictive biomarker of prognosis in breast cancer patients.